Atorvastatin and losartan may upregulate renalase activity in hypertension but not coronary artery diseases: The role of gene polymorphism

Abstract

The aim is to explore the treatment effect of coronary artery disease (CAD) and hypertension on plasma levels of renalase activity and also the possible association of renalase rs10887800 gene polymorphism with CAD and hypertension. A total of 286 patients who received coronary angiography were included in the study. Subjects were divided into four groups including (1) hypertensive with no CAD (H-Tens, n = 60); (2) CAD with hypertension (CAD + H-Tens, n = 71); (3) CAD with no hypertension (CAD, n = 61); and (4) nonhypertensive with no CAD as a control group (Con, n = 69). The plasma renalase activity was measured using the Amplex Red Monoamine Oxidase Assay Kit. Renalase rs10887800 single-nucleotide polymorphisms (SNPs) were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Atorvastatin (P = 0.005), losartan (P < 0.001), and captopril (P = 0.001) were administered significantly more in case groups compared with the Con group. Significant higher and lower levels of renalase activity were observed in H-Tens and CAD patients compared with control subjects (P < 0.001 for both comparisons). Furthermore, no significant differences were obtained in the risk or protective effects of renalase rs10887800 SNP against hypertension and/or CAD in both recessive and dominant genetic models (P > 0.05).According to the findings of the present study, atorvastatin and losartan therapy assumes considerable significance in alleviating hypertension, but not CAD, by increasing the renalase activity. Furthermore, it was found that renalase rs10887800 is less likely a predisposing factor for susceptibility to hypertension and/or CAD in an Iranian southeast population. K E Y W O R D S atorvastatin, captopril, coronary artery disease, hypertension, losartan, renalase 1 | INTRODUCTION Cardiovascular diseases (CVDs), particularly coronary artery disease (CAD) and hypertension, are the leading causes of high rates of morbidity and mortality worldwide. 1-3 It is widely believed that CAD and hypertension are influenced by multiple factors, including environmental, metabolic, and genetic determinants which manifest severe disorders in cases that metabolic and genetic factors are combined. 4-8 As a newly J Cell Biochem. 2019;120:9159-9171. wileyonlinelibrary.com/journal/jcb

Malvidin prevents lipopolysaccharide‐induced oxidative stress and inflammation in human peripheral blood mononuclear cells

“…Chronic inflammation may directly or indirectly contribute to a variety of chronic diseases including several cancers, autoimmune diseases, cardiovascular disease (CVD), diabetes, neurodegenerative diseases, and infections 1 . A variety of inflammatory and immune cells result in the pathophysiology of diseases associated with inflammation 2,3 . Tumor necrosis factor‐alpha (TNF‐α), interleukin‐1beta (IL‐1β), IL‐8, IL‐6, and nitric oxide (NO) are generated by inflammatory and immune cells in response to LPS stimulation 4 .…”

Comparison of QT dispersion in patients with ST elevation acute myocardial infarction (STEMI) before and after treatment by streptokinase versus primary percutaneous coronary intervention (PCI)

“…The probability of developing thrombosis in patients with ST-elevation myocardial infarction (STEMI) is more than 90%. Thus, reperfusion is the most important treatment for patients with STEMI [ 1 , 2 ].…”

Associations between renalase concentration and the occurrence of selected diseases

“…Cytoprotective properties of renalase have been demonstrated during an experiment with rats after subtotal (5/6) nephrec-tomy. Systemic delivery of renalase in the trial group prevented kidney injury and cardiac remodelling [14]. The impact of salt-intake on renalase expression in kidneys was confirmed by two independent experiments using Dahl salt-sensitive rats and Sprague-Dawley rats.…”

“…Understanding the renalase impact on oscillations of catecholamine levels explains its role in the regulation of blood pressure, myocardial contraction, heart rate, and vascular tone [14]. Coronary artery disease is first among cardiovascular diseases in terms of occurrence and mortality.…”